Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific AC066615.1 ENSG00000259752 15 47133652-47134026 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level HPA042797 Uncertain Tissue enhanced 0 endometrium: 2.1;urinary bladder: 1.7 esophagus: 1.4 AC074033.1 ENSG00000281137 3 169483709-169483946 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 endometrium: 2.0 thyroid gland: 0.9 ADAMTS7 ADAM-TS7, DKFZp434H204 ENSG00000136378 ADAM metallopeptidase with thrombospondin type 1 motif, 7 15 78759203-78811431 Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045284, HPA048453 Uncertain Approved Vesicles Tissue enhanced 0 endometrium: 7.2 heart muscle: 4.7 ADAMTSL1 ADAMTSR1, C9orf94, FLJ35283 ENSG00000178031 ADAMTS-like 1 9 18473894-18910950 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057437 Uncertain Tissue enhanced 0 endometrium: 20.7 smooth muscle: 16.1 ADRA2C ADRA2L2, ADRA2RL2, ADRARL2 ENSG00000184160 Adrenoceptor alpha 2C 4 3766348-3768526 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA057688 Uncertain Tissue enhanced 0 cervix, uterine: 21.0;endometrium: 26.0;seminal vesicle: 26.7 fallopian tube: 7.9 ALDH1A2 RALDH2 ENSG00000128918 Aldehyde dehydrogenase 1 family, member A2 15 57953424-58497866 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010022 Approved Tissue enhanced 0 endometrium: 117.2;fallopian tube: 107.1 testis: 96.5 AP000349.2 ENSG00000280178 22 23782283-23783958 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cervix, uterine: 2.2;endometrium: 4.0 smooth muscle: 1.6 ASPN FLJ20129, PLAP1, SLRR1C ENSG00000106819 Asporin 9 92456205-92482506 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008435, HPA024230 Approved Supported Nucleoplasm
Vesicles Tissue enhanced 0 endometrium: 114.7;smooth muscle: 159.0 gallbladder: 104.4 BNC2 BSN2, FLJ20043 ENSG00000173068 Basonuclin 2 9 16409503-16870843 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018525 Approved Supported Nucleus
Cytosol Tissue enhanced 0 endometrium: 44.4;ovary: 39.3;smooth muscle: 47.3 fallopian tube: 19.3 C1QTNF6 CTRP6, ZACRP6 ENSG00000133466 C1q and tumor necrosis factor related protein 6 22 37180167-37199385 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002042 Supported Approved Nucleus Tissue enhanced 0 endometrium: 52.2;placenta: 41.1 gallbladder: 13.5 CDH13 CDHH ENSG00000140945 Cadherin 13 16 82626803-83800640 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001380, CAB025863 Supported Supported Plasma membrane Tissue enhanced 0 endometrium: 82.5 cervix: 72.5 CEMIP IR2155535, KIAA1199, TMEM2L ENSG00000103888 Cell migration inducing protein, hyaluronan binding 15 80779343-80951776 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 endometrium: 54.5 epididymis: 17.0 CPXM1 CPX-1, CPX1, CPXM ENSG00000088882 Carboxypeptidase X (M14 family), member 1 20 2794069-2800637 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 endometrium: 130.2;gallbladder: 132.9 urinary bladder: 77.4 CTC-273B12.7 ENSG00000268465 19 48465837-48472431 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 colon: 1.2;endometrium: 1.3;testis: 2.8 small intestine: 0.6 CYP24A1 CP24, CYP24, P450-CC24 ENSG00000019186 Cytochrome P450, family 24, subfamily A, polypeptide 1 20 54153449-54173973 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA022261, HPA063771 Supported Supported Nucleoplasm
Plasma membrane
Mitochondria Tissue enhanced 0 endometrium: 24.8;urinary bladder: 52.7 placenta: 13.9 DLX5 ENSG00000105880 Distal-less homeobox 5 7 97020392-97025097 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA005670 Approved Uncertain Nucleus Tissue enhanced 0 endometrium: 20.1;placenta: 13.5;skin: 17.2 cervix: 9.5 DLX6 ENSG00000006377 Distal-less homeobox 6 7 97005548-97011039 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA030608, HPA061460 Uncertain Approved Nuclear bodies Tissue enhanced 0 endometrium: 4.4;placenta: 4.3;testis: 5.4 cervix: 3.0 DPP6 DPPX ENSG00000130226 Dipeptidyl-peptidase 6 7 153887097-154894285 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050509 Supported Supported Tissue enhanced 0 cerebral cortex: 51.2;endometrium: 27.4 smooth muscle: 15.2 EPO EP ENSG00000130427 Erythropoietin 7 100720800-100723700 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB010336 Supported Tissue enhanced 0 cervix, uterine: 2.0;endometrium: 1.7;liver: 1.7 prostate: 1.1 FAP DPPIV ENSG00000078098 Fibroblast activation protein, alpha 2 162170684-162245151 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059739 Approved Tissue enhanced 0 endometrium: 50.4 smooth muscle: 37.9 FBXL22 Fbl22, FLJ39626 ENSG00000197361 F-box and leucine-rich repeat protein 22 15 63597353-63602428 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA047624, HPA054627 Uncertain Uncertain Nucleoli
Cytosol Tissue enhanced 0 endometrium: 45.1;seminal vesicle: 34.9;smooth muscle: 36.2 prostate: 17.4 FOXL2 BPES, BPES1 ENSG00000183770 Forkhead box L2 3 138944224-138947140 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069613 Supported Supported Nucleus
Cytokinetic bridge Tissue enhanced 0 endometrium: 12.1;ovary: 29.6;parathyroid gland: 24.2 fallopian tube: 7.6 FOXL2NB C3orf72, FLJ43329 ENSG00000206262 FOXL2 neighbor 3 138947234-138953451 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA061017, HPA071790 Supported Nucleoli fibrillar center Tissue enhanced 0 endometrium: 29.1;ovary: 50.7;parathyroid gland: 63.1 fallopian tube: 19.5 FREM1 C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR ENSG00000164946 FRAS1 related extracellular matrix 1 9 14734666-14910995 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 endometrium: 33.8;epididymis: 43.7 smooth muscle: 22.8 FRMD7 FLJ43346, NYS, NYS1 ENSG00000165694 FERM domain containing 7 X 132076993-132128020 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA000886 Uncertain Tissue enhanced 0 endometrium: 2.8;kidney: 3.0;smooth muscle: 3.4 seminal vesicle: 0.7 GAL3ST3 GAL3ST2 ENSG00000175229 Galactose-3-O-sulfotransferase 3 11 66041952-66049180 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 4.3;endometrium: 4.3;smooth muscle: 4.7;thyroid gland: 8.2 seminal vesicle: 2.4 GAS1 ENSG00000180447 Growth arrest-specific 1 9 86944363-86947189 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB024164, HPA036085, HPA066902 Approved Approved Nuclear speckles Tissue enhanced 0 endometrium: 110.4 smooth muscle: 73.6 GJC1 CX45, GJA7 ENSG00000182963 Gap junction protein, gamma 1, 45kDa 17 44798448-44830816 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071788 Uncertain Nucleoli
Cell Junctions
Cytosol Tissue enhanced 0 endometrium: 43.9;placenta: 50.9;smooth muscle: 48.2 seminal vesicle: 27.0 GLI1 GLI ENSG00000111087 GLI family zinc finger 1 12 57460135-57472262 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009460, HPA065172 Uncertain Supported Nucleoplasm
Cytosol Tissue enhanced 0 cervix, uterine: 15.0;endometrium: 15.1 gallbladder: 8.5 GNLY D2S69E, LAG-2, LAG2, NKG5, TLA519 ENSG00000115523 Granulysin 2 85685175-85698854 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025186, HPA058021 Supported Tissue enhanced 0 bone marrow: 153.1;endometrium: 113.5;spleen: 114.5 lung: 51.2 HAND2 bHLHa26, dHand, Hed, Thing2 ENSG00000164107 Heart and neural crest derivatives expressed 2 4 173524969-173530229 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019591, CAB025576 Approved Supported Nucleoplasm
Vesicles Tissue enhanced 0 endometrium: 83.7 smooth muscle: 77.6 HOXA10 HOX1, HOX1H ENSG00000253293 Homeobox A10 7 27170591-27180261 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019384 Approved Supported Nucleoplasm
Nuclear bodies Tissue enhanced 0 endometrium: 116.3;smooth muscle: 67.0 prostate: 42.4 HOXA10-HOXA9 ENSG00000257184 7 27163535-27180013 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 endometrium: 1.0 prostate: 0.3 HOXA11 HOX1, HOX1I ENSG00000005073 Homeobox A11 7 27181510-27185223 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA006770, HPA035623 Supported Supported Nucleoplasm Tissue enhanced 0 endometrium: 96.0;smooth muscle: 67.7 cervix: 18.3 HOXD10 HOX4, HOX4D ENSG00000128710 Homeobox D10 2 176108790-176119942 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA065871 Approved Nucleoplasm
Cytosol
Cytoplasmic bodies Tissue enhanced 0 endometrium: 48.0;smooth muscle: 24.9 kidney: 12.6 HOXD11 HOX4, HOX4F ENSG00000128713 Homeobox D11 2 176104216-176109754 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level No evidence HPA055155 Approved Nucleoplasm Tissue enhanced 0 endometrium: 5.9 smooth muscle: 1.6 HOXD4 HOX4, HOX4B ENSG00000170166 Homeobox D4 2 176151222-176153226 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA054383, HPA070349 Approved Validated Nucleus
Cell Junctions Tissue enhanced 0 endometrium: 23.5;epididymis: 22.6 fallopian tube: 15.4 HOXD9 HOX4, HOX4C ENSG00000128709 Homeobox D9 2 176122720-176124937 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA068683 Supported Nucleus
Nucleoli Tissue enhanced 0 endometrium: 45.3 smooth muscle: 23.6 HTR1E 5-HT1E ENSG00000168830 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled 6 86937306-87016683 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA004931 Approved Tissue enhanced 0 endometrium: 2.4;ovary: 4.9 cerebral cortex: 1.9 HTR2B 5-HT(2B), 5-HT2B ENSG00000135914 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled 2 231108230-231125118 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011448, HPA012867, HPA063658 Approved Approved Nucleoplasm Tissue enhanced 0 cervix, uterine: 31.1;endometrium: 30.0;smooth muscle: 23.0 adrenal gland: 19.1 IL11 AGIF, IL-11 ENSG00000095752 Interleukin 11 19 55364389-55370463 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044955 Uncertain Mitochondria Tissue enhanced 0 appendix: 5.8;endometrium: 5.2;gallbladder: 4.9 skin: 1.7 INHBA ENSG00000122641 Inhibin, beta A 7 41685114-41703108 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020031 Uncertain Tissue enhanced 0 endometrium: 28.7;gallbladder: 35.0 lung: 16.4 IRS4 IRS-4, PY160 ENSG00000133124 Insulin receptor substrate 4 X 108732482-108736409 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017372 Uncertain Tissue enhanced 0 endometrium: 1.7;ovary: 4.4;thyroid gland: 2.1 cervix: 1.1 ITGA11 HsT18964 ENSG00000137809 Integrin, alpha 11 15 68296533-68432162 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051813 Uncertain Tissue enhanced 0 cervix, uterine: 54.4;endometrium: 52.2;smooth muscle: 74.7 epididymis: 22.7 KCNAB3 AKR6A9, KCNA3B ENSG00000170049 Potassium channel, voltage gated subfamily A regulatory beta subunit 3 17 7921859-7929803 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA077993 Approved Mitochondria Tissue enhanced 0 endometrium: 14.5;smooth muscle: 8.5 cerebral cortex: 4.7 KCNG1 K13, KCNG, kH2, Kv6.1 ENSG00000026559 Potassium channel, voltage gated modifier subfamily G, member 1 20 51003656-51023129 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039530, HPA040024 Approved Validated Vesicles Tissue enhanced 0 endometrium: 23.4;seminal vesicle: 17.9 placenta: 10.8 KIAA1644 ENSG00000138944 KIAA1644 22 44243667-44312851 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051178 Uncertain Approved Vesicles
Cytosol Tissue enhanced 0 cerebral cortex: 27.6;endometrium: 42.5;smooth muscle: 44.0 cervix: 19.1 KLHL13 BKLHD2, FLJ10262, KIAA1309 ENSG00000003096 Kelch-like family member 13 X 117897813-118117340 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046039, HPA059901 Approved Approved Cytosol Tissue enhanced 0 endometrium: 52.2 smooth muscle: 43.3 LINGO2 LERN3, LRRN6C ENSG00000174482 Leucine rich repeat and Ig domain containing 2 9 27948078-28670286 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA016633, CAB025361 Approved Tissue enhanced 0 endometrium: 11.8;smooth muscle: 12.8 thyroid gland: 4.9 MEIS3 DKFZp547H236, MRG2 ENSG00000105419 Meis homeobox 3 19 47403124-47419523 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA046699 Uncertain Approved Nucleoplasm Tissue enhanced 0 endometrium: 82.2 cerebral cortex: 65.0 MEX3A RKHD4 ENSG00000254726 Mex-3 RNA binding family member A 1 156072013-156081998 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062703 Supported Cytosol Tissue enhanced 0 endometrium: 5.9;ovary: 5.9 cerebral cortex: 4.1 MITF bHLHe32, MI, WS2, WS2A ENSG00000187098 Microphthalmia-associated transcription factor 3 69739435-69968337 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002578, HPA003259 Supported Tissue enhanced 0 cervix, uterine: 80.4;endometrium: 78.8 smooth muscle: 68.6 MMP3 STMY, STMY1 ENSG00000149968 Matrix metallopeptidase 3 11 102835801-102843803 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007875 Uncertain Approved Vesicles Tissue enhanced 0 appendix: 26.9;endometrium: 58.7 urinary bladder: 9.2 MOXD1 dJ248E1.1, DKFZP564G202, MOX ENSG00000079931 Monooxygenase, DBH-like 1 6 132296055-132401545 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035740 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 endometrium: 105.3;smooth muscle: 113.0 seminal vesicle: 53.1 NPAS4 bHLHe79, Le-PAS, NXF, PASD10 ENSG00000174576 Neuronal PAS domain protein 4 11 66421004-66426707 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA039255 Uncertain Tissue enhanced 0 cerebral cortex: 4.1;endometrium: 1.9 smooth muscle: 1.5 OSR2 FLJ90037 ENSG00000164920 Odd-skipped related transciption factor 2 8 98944403-98952104 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA052425, HPA063486 Uncertain Approved Nucleus
Plasma membrane Tissue enhanced 0 endometrium: 204.6;fallopian tube: 143.0 ovary: 102.5 PAMR1 DKFZP586H2123, RAMP ENSG00000149090 Peptidase domain containing associated with muscle regeneration 1 11 35431823-35530300 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cervix, uterine: 86.5;endometrium: 91.9 placenta: 75.5 PCDHA2 ENSG00000204969 Protocadherin alpha 2 5 140794852-141012344 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035653 Uncertain Tissue enhanced 0 endometrium: 1.0 cerebral cortex: 0.9 PCDHB7 PCDH-BETA7 ENSG00000113212 Protocadherin beta 7 5 141172619-141176383 Plasma proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA059271 Approved Tissue enhanced 0 endometrium: 6.6 smooth muscle: 4.4 PLK5 PLK5P, SgK384ps ENSG00000185988 Polo-like kinase 5 19 1524074-1535456 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035024 Approved Tissue enhanced 0 cervix, uterine: 4.5;endometrium: 4.7;testis: 6.9 epididymis: 3.3 PTGFR FP ENSG00000122420 Prostaglandin F receptor (FP) 1 78303884-78539749 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 endometrium: 30.3;smooth muscle: 25.4 urinary bladder: 13.3 RAMP1 ENSG00000132329 Receptor (G protein-coupled) activity modifying protein 1 2 237858893-237912114 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057814 Approved Nucleoplasm
Nuclear membrane Tissue enhanced 0 endometrium: 233.7 smooth muscle: 169.4 RPRM FLJ90327, REPRIMO ENSG00000177519 Reprimo, TP53 dependent G2 arrest mediator candidate 2 153477338-153478808 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 21.3;endometrium: 21.9 smooth muscle: 17.3 RSPO1 FLJ40906, RSPONDIN ENSG00000169218 R-spondin 1 1 37611350-37634923 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA046154 Uncertain Tissue enhanced 0 endometrium: 43.3;fallopian tube: 32.8 smooth muscle: 21.0 RSPO3 FLJ14440, THSD2 ENSG00000146374 R-spondin 3 6 127118604-127197765 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA029957 Approved Tissue enhanced 0 endometrium: 102.8;smooth muscle: 102.3 placenta: 72.8 RXFP1 LGR7, RXFPR1 ENSG00000171509 Relaxin/insulin-like family peptide receptor 1 4 158315311-158653372 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA027067 Approved Tissue enhanced 0 cerebral cortex: 21.7;endometrium: 10.1 adrenal gland: 5.7 SERTM1 C13orf36 ENSG00000180440 Serine-rich and transmembrane domain containing 1 13 36673912-36697839 Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence HPA054814, HPA070485 Uncertain Supported Vesicles Tissue enhanced 0 cerebral cortex: 47.8;endometrium: 37.3;fallopian tube: 29.3 smooth muscle: 24.5 SLC7A3 ATRC3, CAT-3, FLJ14541 ENSG00000165349 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 X 70925582-70931125 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003629 Approved Tissue enhanced 0 endometrium: 7.8;prostate: 9.6;seminal vesicle: 7.4 smooth muscle: 4.0 SLITRK3 KIAA0848 ENSG00000121871 SLIT and NTRK-like family, member 3 3 165186720-165197109 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA017636 Approved Mitochondria Tissue enhanced 0 cerebral cortex: 17.4;endometrium: 12.4 fallopian tube: 9.7 SNCAIP SYPH1 ENSG00000064692 Synuclein, alpha interacting protein 5 122311354-122464219 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA064687 Uncertain Supported Cytoplasmic bodies Tissue enhanced 0 endometrium: 30.0;ovary: 43.3 cervix: 26.0 SOX17 ENSG00000164736 SRY (sex determining region Y)-box 17 8 54457935-54460888 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025594, HPA068399 Supported Approved Nucleoplasm Tissue enhanced 0 cervix, uterine: 30.1;endometrium: 32.1;fallopian tube: 30.1 adipose tissue: 14.7 SP5 ENSG00000204335 Sp5 transcription factor 2 170715351-170718078 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA074123 Approved Nucleus
Nucleoli Tissue enhanced 0 endometrium: 3.9 stomach: 2.4 SPON2 DIL1 ENSG00000159674 Spondin 2, extracellular matrix protein 4 1166932-1208962 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040170, HPA066095 Uncertain Approved Vesicles Tissue enhanced 0 endometrium: 105.3;prostate: 96.8 cervix: 53.6 SYTL4 ENSG00000102362 Synaptotagmin-like 4 X 100674491-100732123 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001475, HPA001589 Approved Approved Nucleoplasm
Microtubule organizing center
Cytosol Tissue enhanced 0 endometrium: 71.4;ovary: 83.9 smooth muscle: 48.7 TCF23 bHLHa24, OUT ENSG00000163792 Transcription factor 23 2 27149004-27156974 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 endometrium: 33.7;ovary: 22.6;smooth muscle: 30.5 fallopian tube: 13.9 TGFB1I1 ARA55, Hic-5, TSC-5 ENSG00000140682 Transforming growth factor beta 1 induced transcript 1 16 31471585-31477960 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020844 Approved Supported Focal adhesion sites
Cytosol Tissue enhanced 0 endometrium: 139.7;smooth muscle: 151.9 seminal vesicle: 109.6 TMEM158 p40BBp, RIS1 ENSG00000249992 Transmembrane protein 158 (gene/pseudogene) 3 45224466-45226278 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 endometrium: 32.5;seminal vesicle: 31.8 smooth muscle: 25.4 TMEM200A KIAA1913, TTMC ENSG00000164484 Transmembrane protein 200A 6 130365734-130443063 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014396 Uncertain Tissue enhanced 0 endometrium: 64.8 smooth muscle: 29.0 TMEM200B TTMB ENSG00000253304 Transmembrane protein 200B 1 29119428-29123935 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055254 Uncertain Tissue enhanced 0 endometrium: 68.0 seminal vesicle: 52.6 TNFAIP8L3 FLJ41287 ENSG00000183578 Tumor necrosis factor, alpha-induced protein 8-like 3 15 51056598-51105276 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048372 Uncertain Tissue enhanced 0 endometrium: 118.6;smooth muscle: 105.4 fallopian tube: 33.7 TRPC4 HTRP4, TRP4 ENSG00000133107 Transient receptor potential cation channel, subfamily C, member 4 13 37636636-37870425 Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 endometrium: 18.5;seminal vesicle: 12.0;smooth muscle: 18.2 prostate: 10.7 TSHB ENSG00000134200 Thyroid stimulating hormone, beta 1 115029824-115034309 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 endometrium: 1.7 seminal vesicle: 1.0 TSPAN2 FLJ12082, TSN2, TSPAN-2 ENSG00000134198 Tetraspanin 2 1 115048011-115089500 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015640 Uncertain Approved Nucleoplasm Tissue enhanced 0 endometrium: 71.2;smooth muscle: 64.0 seminal vesicle: 40.1 TWIST1 ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST ENSG00000122691 Twist family bHLH transcription factor 1 7 19020991-19117672 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adipose tissue: 22.7;endometrium: 30.7 placenta: 17.2 WNT5A hWNT5A ENSG00000114251 Wingless-type MMTV integration site family, member 5A 3 55465715-55490539 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 endometrium: 46.3 urinary bladder: 36.5 WT1 AWT1, GUD, WAGR, WIT-2 ENSG00000184937 Wilms tumor 1 11 32387775-32435630 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000327, HPA035717, HPA053848 Supported Supported Nucleoplasm Tissue enhanced 0 endometrium: 112.0;fallopian tube: 123.1;smooth muscle: 78.9 testis: 53.8